299 related articles for article (PubMed ID: 22895794)
1. Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.
Perrone J; DeRoos FJ; Nelson LS
J Med Toxicol; 2012 Dec; 8(4):341-52. PubMed ID: 22895794
[TBL] [Abstract][Full Text] [Related]
2. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
[TBL] [Abstract][Full Text] [Related]
3. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
4. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
[TBL] [Abstract][Full Text] [Related]
6. Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain.
Lin HC; Wang Z; Simoni-Wastila L; Boyd C; Buu A
Prev Med; 2019 Jan; 118():59-65. PubMed ID: 30316875
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of state prescription drug monitoring programs: a state-by-state survey.
Manasco AT; Griggs C; Leeds R; Langlois BK; Breaud AH; Mitchell PM; Weiner SG
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):847-51. PubMed ID: 27061342
[TBL] [Abstract][Full Text] [Related]
8. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.
Irvine JM; Hallvik SE; Hildebran C; Marino M; Beran T; Deyo RA
J Pain; 2014 Jul; 15(7):747-55. PubMed ID: 24787089
[TBL] [Abstract][Full Text] [Related]
9. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
Kohan LR; Elmofty D; Pena I; Liao C
J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
[TBL] [Abstract][Full Text] [Related]
10. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
Brown WC; Whitted K
J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
[TBL] [Abstract][Full Text] [Related]
11. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
[TBL] [Abstract][Full Text] [Related]
12. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
[TBL] [Abstract][Full Text] [Related]
13. Prescription drug monitoring program design and function: A qualitative analysis.
Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
Martello J; Cassidy B; Mitchell A
J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
[TBL] [Abstract][Full Text] [Related]
15. National Estimates and Physician-Reported Impacts of Prescription Drug Monitoring Program Use.
Richwine C; Everson J
J Gen Intern Med; 2023 Mar; 38(4):881-888. PubMed ID: 36229762
[TBL] [Abstract][Full Text] [Related]
16. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
[TBL] [Abstract][Full Text] [Related]
17. How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?
Smith RJ; Kilaru AS; Perrone J; Paciotti B; Barg FK; Gadsden SM; Meisel ZF
Pain Med; 2015 Jun; 16(6):1122-31. PubMed ID: 25688454
[TBL] [Abstract][Full Text] [Related]
18. Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.
Stucke RS; Kelly JL; Mathis KA; Hill MV; Barth RJ
JAMA Surg; 2018 Dec; 153(12):1105-1110. PubMed ID: 30140927
[TBL] [Abstract][Full Text] [Related]
19. Prescription Drug Monitoring Program Use: National Dental PBRN Results.
McCauley JL; Gilbert GH; Cochran DL; Gordan VV; Leite RS; Fillingim RB; Brady KT;
JDR Clin Trans Res; 2019 Apr; 4(2):178-186. PubMed ID: 30931705
[TBL] [Abstract][Full Text] [Related]
20. Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention.
McCauley JL; Leite RS; Melvin CL; Fillingim RB; Brady KT
Subst Abus; 2016; 37(1):9-14. PubMed ID: 26675303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
